WHO ICTRP trial
A study to assess the efficacy and safety of nemolizumab (CD14152) in subjects…
EUCTR2019-004789-17-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-004789-17-FR |
|---|---|
| Public title | A study to assess the efficacy and safety of nemolizumab (CD14152) in subjects with prurigo nodularis (PN) |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis - A study to assess the efficacy and safety of nemolizumab in subjects with prurigo nodularis |
| Primary sponsor | Galderma S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;France;Canada;Poland;Belgium;Spain;Netherlands;Switzerland |
| Conditions | Prurigo Nodularis MedDRA version: 20.0 Level: LLT Classification code 10037084 Term: Prurigo nodularis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Product Name: CD14152 Product Code: CD14152 Pharmaceutical Form: Powder and solution for solution for injection INN or Proposed INN: NEMOLIZUMAB CAS Number: 1476039-58-3 Current Sponsor code: CD14152 / CIM331 Other descriptive name… |
| Registration date | Apr 15, 2020 |
| Target size | 240 |
| Secondary IDs | RD.06.SPR.203065;117122 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: